EPIDEMIOLOGIC TYPING OF KLEBSIELLAE WITH EXTENDED-SPECTRUM BETA-LACTAMASES FROM EUROPEAN INTENSIVE-CARE UNITS

Citation
Mf. Yuan et al., EPIDEMIOLOGIC TYPING OF KLEBSIELLAE WITH EXTENDED-SPECTRUM BETA-LACTAMASES FROM EUROPEAN INTENSIVE-CARE UNITS, Journal of antimicrobial chemotherapy, 41(5), 1998, pp. 527-539
Citations number
30
Categorie Soggetti
Microbiology,"Pharmacology & Pharmacy","Infectious Diseases
Journal title
Journal of antimicrobial chemotherapy
ISSN journal
03057453 → ACNP
Volume
41
Issue
5
Year of publication
1998
Pages
527 - 539
Database
ISI
SICI code
Abstract
Extended-spectrum beta-lactamases (ESBLs) are an increasing cause of r esistance to oxyimino-aminothiazolyl cephalosporins, especially in kle bsiellae from 35 intensive care units (ICUs) in southern and western E urope. The present study examined the extent to which this distributio n reflected epidemic strain spread, as against the distribution of ESB L genes into unrelated strains. All 220 ESBL producers were subjected to capsular serotyping and pulsed-field gel DNA electrophoresis (PFGE) . beta-Lactamases were typed for strains isolated on three or more occ asions, with the emphasis on SHV enzymes, as these were commoner than TEM variant. Serotyping and PFGE typing defined 85 distinct strains, f rom 23 of the 35 participating centres. Of 14 centres that contributed five or more ESBL producers, all sent different strains in contributi ons of 17-21 ESBL-producing isolates. Nevertheless, epidemic strains-d efined as those represented by three or more isolates-accounted for a majority (61%) of the collection. Fifty-two isolates of the same serot ype K25 (occasionally acapsular) strain with SHV-4 beta-lactamase were recovered at two French hospitals and one in Belgium. This strain has been found by others in France, and has been become particularly wide spread. Another single strain was found in two separate Portuguese cen tres, and many individual hospitals had one or more epidemic strain(s) , as well as a scatter of diverse ESBL producers. Major variation in a ntibiogram and plasmid profile was apparent within strains, with some intra-strain variation in beta-lactamase type. These data imply a flui d situation, with resistance determinants being gained, modified or lo st. The endemicity of ESBL producers is disturbing since it limits the potential for control by blocking strain spread, while the diversity within strains is disturbing because it complicates the design of anti biotic policies even during 'single strain' outbreaks.